DOUG SPOSETTA: Open Payments
NPI 1598131237 · AUSTINTOWN, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,540 in 212 payments from 27 companies in 2025. Trend: 2023 $3,623 · 2024 $3,347 · 2025 $3,540
Food & beverage: $3,540
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 35 | $613 |
| AstraZeneca Pharmaceuticals LP | 30 | $589 |
| PFIZER INC. | 33 | $445 |
| Vanda Pharmaceuticals Inc. | 19 | $308 |
| Novo Nordisk Inc | 16 | $277 |
| Lilly USA, LLC | 18 | $242 |
| Amgen Inc. | 13 | $211 |
| Otsuka America Pharmaceutical, Inc. | 7 | $116 |
| GlaxoSmithKline, LLC. | 5 | $74 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $69 |
Products named: AIRSUPRA, NURTEC ODT, FANAPT, UBRELVY, QULIPTA, OTEZLA, Ozempic, MOUNJARO.
Industry payments across OH — which companies pay providers there.
